Verve Therapeutics, Inc.
NASDAQ:VERV
5.46 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 141.49 | 144.2 | 206.18 | 78.37 | 70.042 | 508.687 | 115.412 | 550.71 | 72.889 | 91.42 | 64.33 | 148.134 | 387.446 | 99.397 | 8.993 | -18.782 |
Short Term Investments
| 434.458 | 462.167 | 417.77 | 406.856 | 392.434 | 424.941 | 439.396 | 273.691 | 220.672 | 231.879 | 296.112 | 241.076 | 30.178 | 50.126 | 63.119 | 37.564 |
Cash and Short Term Investments
| 575.948 | 606.367 | 623.95 | 485.226 | 462.476 | 508.687 | 554.808 | 550.71 | 293.561 | 323.299 | 360.442 | 389.21 | 417.624 | 149.523 | 72.112 | 18.782 |
Net Receivables
| 3.04 | 5.767 | 5.897 | 3.145 | 2.093 | 1.404 | 1.012 | 0.929 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | -9.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 11.899 | 8.192 | 8.102 | 9.89 | 8.497 | 7.696 | 7.339 | 9.991 | 5.083 | 5.531 | 6.686 | 5.227 | 1.94 | 2.318 | 1.854 | 0 |
Total Current Assets
| 590.887 | 620.326 | 637.949 | 498.261 | 473.066 | 508.687 | 563.159 | 561.63 | 298.644 | 328.83 | 367.128 | 394.437 | 419.564 | 151.841 | 73.966 | 18.782 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 101.931 | 104.551 | 107.8 | 107.844 | 110.018 | 111.056 | 110.655 | 106.491 | 13.193 | 12.472 | 9.063 | 8.909 | 6.417 | 5.202 | 3.984 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 4.774 | 4.774 | 4.774 | 4.774 | 4.824 | 4.824 | 4.824 | 4.824 | 5.237 | 5.237 | 5.237 | 5.237 | 0.463 | 0.463 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 3.318 | 2.706 | 2.165 | 1.528 | 1.223 | 9.809 | 0.585 | 0.41 | 7.193 | 2.702 | 2.696 | 2.294 | 0.074 | 0.663 | 0.463 | -18.782 |
Total Non-Current Assets
| 110.023 | 112.031 | 114.739 | 114.146 | 116.065 | 125.689 | 116.064 | 111.725 | 25.623 | 20.411 | 16.996 | 16.44 | 6.954 | 6.328 | 4.447 | -18.782 |
Total Assets
| 700.91 | 732.357 | 752.688 | 612.407 | 589.131 | 634.376 | 679.223 | 673.355 | 324.267 | 349.241 | 384.124 | 410.877 | 426.518 | 158.169 | 78.413 | 0 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 6.833 | 3.049 | 6.636 | 1.054 | 3.146 | 3.372 | 2.424 | 0.465 | 6.32 | 2.438 | 20.069 | 3.579 | 1.53 | 2.487 | 0.036 | 0 |
Short Term Debt
| 10.293 | 10.22 | 10.192 | 10.118 | 10.046 | 11.184 | 11.904 | 8.904 | 0.907 | 1.432 | 1.955 | 2.295 | -0.152 | -0.136 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 3.479 | 1.473 | 48.556 | 48.554 | 20.014 | 20.014 | 20.014 | 20.014 | 0 | 0 | -12.992 | 8.127 | 0.152 | 0.136 | 0 | 0 |
Other Current Liabilities
| 19.762 | 16.552 | -28.378 | -25.151 | -0.175 | -1.018 | 0.753 | -0.365 | 18.62 | 10.933 | 12.992 | 6.25 | 7.119 | 4.197 | 7.279 | 0 |
Total Current Liabilities
| 40.367 | 31.294 | 37.006 | 34.575 | 33.031 | 33.552 | 35.095 | 29.018 | 25.847 | 14.803 | 22.024 | 20.251 | 8.649 | 6.684 | 7.315 | 0 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 62.183 | 63.454 | 64.715 | 66.689 | 67.819 | 68.927 | 70.014 | 71.011 | 0.907 | 0 | 1.955 | 0.181 | 0 | 218.919 | 0 | 0 |
Deferred Revenue Non-Current
| 51.153 | 51.733 | 48.556 | 48.554 | 20.014 | 20.014 | 20.014 | 20.014 | 0 | 0 | 0 | 0 | 0.013 | 0.053 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -218.972 | 0 | 0 |
Other Non-Current Liabilities
| 1.113 | 2.807 | 2.909 | 2.22 | 3.045 | 2.407 | 3.168 | 5.369 | 1.18 | 3.048 | 2.793 | 5.51 | 12.46 | 227.916 | 135.007 | 0 |
Total Non-Current Liabilities
| 114.449 | 117.994 | 116.18 | 117.463 | 90.878 | 91.348 | 93.196 | 96.394 | 2.087 | 3.048 | 4.748 | 5.691 | 12.473 | 227.916 | 135.007 | 0 |
Total Liabilities
| 154.816 | 149.288 | 153.186 | 152.038 | 123.909 | 124.9 | 128.291 | 125.412 | 27.934 | 17.851 | 26.772 | 25.942 | 21.122 | 234.6 | 142.322 | 0 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 410.877 | 426.518 | 218.919 | 125.16 | 25.48 |
Common Stock
| 0.085 | 0.084 | 0.082 | 0.064 | 0.062 | 0.062 | 0.062 | 0.061 | 0.049 | 0.049 | 0.049 | 0.048 | 0.048 | 0.003 | 0.003 | 0 |
Retained Earnings
| -642.846 | -593.041 | -544.305 | -495.953 | -450.195 | -396.212 | -344.237 | -303.152 | -257.962 | -217.016 | -186.85 | -155.513 | -132.764 | -79.799 | -66.536 | 0 |
Accumulated Other Comprehensive Income/Loss
| -0.615 | -0.5 | 0.272 | -0.597 | -0.754 | -0.237 | -0.694 | -0.92 | -0.938 | -0.732 | -0.228 | -0.002 | 0.003 | 0.007 | 0.008 | -19.553 |
Other Total Stockholders Equity
| 1,189.47 | 1,176.526 | 1,143.453 | 956.855 | 916.109 | 905.863 | 895.801 | 851.954 | 555.184 | 549.089 | 544.381 | 129.525 | 111.591 | -215.561 | -122.544 | 0 |
Total Shareholders Equity
| 546.094 | 583.069 | 599.502 | 460.369 | 465.222 | 509.476 | 550.932 | 547.943 | 296.333 | 331.39 | 357.352 | 384.935 | 405.396 | -76.431 | -63.909 | 5.927 |
Total Equity
| 546.094 | 583.069 | 599.502 | 460.369 | 465.222 | 509.476 | 550.932 | 547.943 | 296.333 | 331.39 | 357.352 | 384.935 | 405.396 | -76.431 | -63.909 | 5.927 |
Total Liabilities & Shareholders Equity
| 700.91 | 732.357 | 752.688 | 612.407 | 589.131 | 634.376 | 679.223 | 673.355 | 324.267 | 349.241 | 384.124 | 410.877 | 426.518 | 158.169 | 78.413 | 5.927 |